Pharmaceutical Technology1 天
Vebreltinib DR by Apollomics for Non-Small Cell Lung Cancer: Likelihood of Approval
Vebreltinib DR is under clinical development by Apollomics and currently in Phase II for Non-Small Cell Lung Cancer.
Pharmaceutical Technology1 天
Vebreltinib DR by Apollomics for Head And Neck Cancer: Likelihood of Approval
Vebreltinib DR is under clinical development by Apollomics and currently in Phase II for Head And Neck Cancer.